Genopathy
Gene-Disorder Association · Article
Gene
GATA3
GATA Binding Protein 3
Manually curatedApproved treatment annotated
Association Review

In brief

The association between GATA3 (GATA Binding Protein 3) and Leukemia, Acute Lymphoblastic is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 5
Compounds 10
Trials 662of 6,490 via GATA3 compounds
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
GATA3

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Leukemia, Acute Lymphoblastic

The disorder

21 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Interventions

Therapeutics

10 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

6,490 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Provenance

References & sources

6 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access